Showing results (51-60 of 125) with videos related to
Sort By:
Pageof 13
Drug and Alcohol Dependence|June 4, 2021
Non-abstinent treatment outcomes for cannabis use disorderFrances R Levin, John J Mariani, C Jean Choi, et al.Alcoholism, Clinical and Experimental Research|October 26, 2021
Is extended release naltrexone superior to buprenorphine-naloxone to reduce drinking among outpatients receiving treatment for opioid use disorder? A secondary analysis of the CTN X:BOT trialJohn D Roache, Martina Pavlicova, Aimee Campbell, et al.American Journal of Hypertension|September 8, 2025
Dynamical Regulation of Blood Pressure and Cognitive FunctionJoshua Sweigert, Tara Gruenewald, Margie Lachman, et al.Addictive Behaviors|July 4, 2020
Extended-release naltrexone versus buprenorphine-naloxone to treat opioid use disorder among black adultsAngela M Haeny, LaTrice Montgomery, A Kathleen Burlew, et al.Journal of HIV/AIDS & Social Services|October 22, 2016
Barriers to Condom Use: Results for Men and Women Enrolled in HIV Risk Reduction Trials in Outpatient Drug TreatmentAimee N C Campbell, Audrey J Brooks, Martina Pavlicova, et al.Addiction (Abingdon, England)|February 26, 2013
Reducing heavy drinking in HIV primary care: a randomized trial of brief intervention, with and without technological enhancementDeborah S Hasin, Efrat Aharonovich, Ann O'Leary, et al.Drug and Alcohol Dependence|October 7, 2014
Do withdrawal-like symptoms mediate increased marijuana smoking in individuals treated with venlafaxine-XR?Meredith A Kelly, Martina Pavlicova, Andrew Glass, et al.Nature Biomedical Engineering|July 30, 2021
Enhancing the tropism of bacteria via genetically programmed biosensorsTiffany Chien, Tetsuhiro Harimoto, Benjamin Kepecs, et al.Journal of Substance Abuse Treatment|June 12, 2021
Reductions in tobacco use in naltrexone, relative to buprenorphine-maintained individuals with opioid use disorder: Secondary analysis from the National Drug Abuse Treatment Clinical Trials NetworkLaTrice Montgomery, Theresa Winhusen, Jennifer Scodes, et al.Journal of Addiction Medicine|February 11, 2020
Secondary Analysis of Pain Outcomes in a Large Pragmatic Randomized Trial of Buprenorphine/Naloxone Versus Methadone for Opioid Use DisorderMatisyahu Shulman, Sean X Luo, Aimee N C Campbell, et al.Pageof 13